Open drops in ophthalmology offices: Expiration and contamination

Ophthalmic Surgery and Lasers

Volumn 30, Issue 7, 1999, Pages 540-546

  Wessels, Izak F ^a,b   Bekendam, Pamela ^b   Calvin, W Scott ^b   Zimmerman, Grenith J ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CYCLOPLEGIC AGENT; EYE DROPS; STEROID;

ARTICLE; BACTERIUM COLONY; DRUG CONTAMINATION; DRUG LABELING; EXPIRATION DATE; MICROCOCCUS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL;

DRUG CONTAMINATION; DRUG LABELING; DRUG STABILITY; DRUG STORAGE; HUMANS; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGY; PHYSICIANS' OFFICES;

EID: 0032816512     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mayo MS, Schlitzer RL, Ward MA, Wilson LA, Ahearn DG. Association of pseudomonas and serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol. 1987;25:1398-1400.
2. Templeton WC, III, Eiferman RA, Snyder JW, Melo JC, Raff MJ. Serratia keratitis transmitted by contaminated eyedroppers. Am J Ophthalmol. 1982:93:723-726.
3. Donzis PB, Mondino BJ, Weissman BA, Bruckner DA. Microbial contamination of contact lens care systems. Am J Ophthalmol. 1987;104:325-333.
4. Raynaud C, Laeran H, Rigal D, Bonicel P. Bacterial contamination of eyedrops in clinical use. J Fr Ophthalmol. 1997;20:17-24.
5. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications. Arch Ophthalmol. 1992;110:82-85.
6. Geyer O, Bottone EJ, Podos SM, Schumer RA, Asbell PA. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol. 1995;79:376-379.
7. Palmberg R, Gutierrez YS, Miller D, Feuer WJ, Anderson DR. Potential bacterial contamination of eyedrops used for tonometry. Am J Ophthalmol. 1994;117:578-582.
8. Parment P, Ronnerstam R, Walder M. Persistence of Serratia marcescens, Serratia liquefaciens and E. coli in solutions for contact lenses. Acta Ophthalmol [Copenh]. 1986;64:456-462.
9. Coad CT, Osato MS, Wilhelmus KR. Bacterial contamination of eye drop dispensers. Am J Ophthalmol. 1984;98:548-551.
10. Stewart HL. Prolonged antibacterial activity of fluorescein-anesthetic solution. Arch Ophthalmol. 1972;88:385-387.
11. Palmberg R, Gutierrez YS, Miller D, Feuer W, Anderson DR. Potential bacterial contamination of eyedrops used for tonometry. Am J Ophthalmol. 1994:117:578-582.
12. Aylward GW, Wilson RS. Contamination of dropper bottles with tear fluid in an ophthalmic outpatient clinic. BMJ. 1987;294:1597.
13. Coven EJ. Is your office safe? Yes. Cornea. 1990;9(Suppl):S41-S43.
14. Farris RL. Is your office safe? No. Cornea. 1990;9(Suppl):S44-S46.
15. Tamer HR, Sweet BV, Ross M B. Use and sterility of multi-dose ophthalmic medications. Am J Hosp Pharm. 1994;51:500-502.
16. Livingstone DJ, Hanlon DW, Dyke S. Evaluation of an extended period of use for preserved eye drops in hospital practice. Br J Ophthalmol. 1998 82:473-475.
17. Stevenson JD, Matheson MM. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing. Br J Ophthalmol. 1992;76:36-38.
18. Clark PJ, Ong B, Stanley CB. Contamination of diagnostic ophthalmic solutions in primary eye care settings. Mil Med. 1997;162:501-506.
19. Oldham GB, Andrew V. Control of microbiologic contamination in unpreserved eyedrops. Br J Ophthalmol. 1996;80:588-591.
20. Abdelaziz AA, Ashour MS, Heni H, el-Tayeb OM. Microbial contamination of cosmetics and personal care items in Egypt-eye shadows, mascaras and face creams. J Clin Pharm Ther. 1989;14:21-28.